Variant report
Variant | nsv523866 |
---|---|
Chromosome Location | chr5:104969958-104992914 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542889048 | chr5:104974010-104974011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530726939 | chr5:104974211-104974212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556451937 | chr5:104974214-104974215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376356827 | chr5:104974262-104974263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559662918 | chr5:104974305-104974306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184609544 | chr5:104974308-104974309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552124442 | chr5:104974312-104974313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565349454 | chr5:104974353-104974354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs55661616 | chr5:104974411-104974412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570716225 | chr5:104974428-104974429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189170716 | chr5:104974429-104974430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141114250 | chr5:104974461-104974462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs36038453 | chr5:104974499-104974500 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs368071411 | chr5:104974532-104974533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561042246 | chr5:104974585-104974586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182046196 | chr5:104974587-104974588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542047965 | chr5:104974678-104974679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566024092 | chr5:104974680-104974681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577157153 | chr5:104974684-104974685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534615871 | chr5:104974710-104974711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557892982 | chr5:104974711-104974712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544487652 | chr5:104974725-104974726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs141912848 | chr5:104974726-104974727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149821321 | chr5:104974762-104974763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145836801 | chr5:104974780-104974781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141598505 | chr5:104974858-104974859 | Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147063952 | chr5:104974866-104974867 | Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187654123 | chr5:104974924-104974925 | Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552554543 | chr5:104974949-104974950 | Active TSS Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573444898 | chr5:104975004-104975005 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545395968 | chr5:104975009-104975010 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138258027 | chr5:104975170-104975171 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568048150 | chr5:104975218-104975219 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531040827 | chr5:104975292-104975293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544703843 | chr5:104975306-104975307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535133979 | chr5:104975324-104975325 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561409169 | chr5:104975337-104975338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35748824 | chr5:104975340-104975341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113387230 | chr5:104975367-104975368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546968615 | chr5:104975385-104975386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566761213 | chr5:104975389-104975390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528353482 | chr5:104975454-104975455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551404952 | chr5:104975458-104975459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs142352572 | chr5:104975462-104975463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536877243 | chr5:104975468-104975469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190778525 | chr5:104975537-104975538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566978012 | chr5:104975550-104975551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535954512 | chr5:104975585-104975586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552519847 | chr5:104975631-104975632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143251895 | chr5:104975636-104975637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 16773561 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:104974000-104974400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr5:104974000-104974600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr5:104974000-104974600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr5:104974000-104975200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr5:104974000-104975400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr5:104974200-104975000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr5:104974800-104975000 | ZNF genes & repeats | Pancreas | Pancrea |
8 | chr5:104974800-104975200 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr5:104974800-104975200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr5:104974800-104975200 | Enhancers | Placenta | Placenta |
11 | chr5:104975200-104977200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |